Latest News
15-Jan-2021 Vaccine Supplies at Risk without Indemnity for Cos: Poonawalla
15-Jan-2021 Only ‘Severe’ Comorbid Cases to Get Priority in First Phase
14-Jan-2021 Vax Cos to be Liable for Adverse Effects of Jabs
14-Jan-2021 WHO asks Serum for Covishield Trial Data for Pre-Qualification
13-Jan-2021 Daily New Cases Down to the Lowest Since June
  more...
Latest Reports
Jan-21 Ample catalysts to sustain luster - HDFC Securities  
Dec-20 Well-positioned in medium term; short-term normalization likely - Emkay Research  
Dec-20 API industry: Well-positioned in medium term; short-term normalization likely - Emkay Research  
Dec-20 IPM growth decelerates sharply in Nov'20 - Emkay Research  
Dec-20 Cipla's Revlimid settlement - Emkay Research  
  more...

Quarterly Summary September-2020
Desc Current Previous Per.Chg
Sales 48431.5 43840.0 10.5
Otherincome 981.2 2439.7 -59.8
Expense 36423.3 33949.1 7.3
RawMaterial 15736.7 13767.3 14.3
StaffCost 6884.1 6437.0 6.9
ExciseDuty 62.2 1.0 6181.8
OtherExp 10008.8 9936.0 0.7
Interest 942.1 1271.4 -25.9
GrossProfit 12585.5 11748.3 7.1
Depreciation 2064.5 1949.3 5.9
Tax 2138.0 906.2 135.9
NetProfit 8272.7 8916.5 -7.2
Total.Comp 163 -- --
Source: ETIG Database

Sectoral Companies As on 15 Jan 2021
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 144917.72
Divi's Lab 96695.47
Dr.Reddy's 86602.39
Cipla 66415.19
Aurobindo Ph 54857.82
Biocon 54810.00
Cadila Healt 49956.56
Lupin 49574.35
Torrent Phar 45915.31
Gland Pharma 38750.27
Alkem Labora 37093.97
Piramal Entp 36639.47
Abbott (I) 31869.69
  click here for the complete list